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Abstract  
Preeclampsia is a condition characterized by hypertension and microvascular disease that 
is diagnosed during pregnancy.  While the acute symptoms of preeclampsia resolve during the 
postpartum period, extensive evidence has shown a history of preeclampsia establishes a higher 
risk for developing cardiovascular disease (CVD) —the leading killer of women—later in life. 
Yet, the majority of affected women are unaware of their elevated risk. The goal of this project 
was to develop an educational resource to increase awareness of risk, promote self-advocacy and 
provide risk reduction strategies for cardiovascular disease among women after a preeclampsia 
complicated pregnancy. Following a comprehensive review of literature, existing evidence was 
appraised and curated to address the knowledge deficit among women with a history of 
preeclampsia regarding future risk for heart disease and strategies to attenuate their risk. Health 
information from leading authorities including the Preeclampsia Foundation (PF) and the 
American Heart Association (AHA) was synthesized to produce efficient and effective evidence-
based patient education to promote awareness and strategic approaches to primary and secondary 
prevention strategies, guided by the Orem Self Care Deficit Theory. Stakeholders at the 
academic medical center implementation site, including nurse educators and the patient 
education resource team, informed the project implementation in collaboration with content 
experts. Anticipatory guidance to promote the project outcomes were incorporated into patient 
education materials provided at discharge to all women with a diagnosis of preeclampsia. Patient 
education was implemented at the Ohio State University Wexner Medical Center (OSUWMC) in 
December 2018 and was linked to the patient’s MyChart and accessible on OSUWMC’s patient 
education platform. Equipped with the awareness to bridge the current gap in clinical practice, 
Running Head: CVD risk reduction following preeclampsia 
women at risk for CVD after preeclampsia should be educated to self-advocate for their long-
term cardiovascular and overall health.  
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Chapter I: Statement of the Problem 
Introduction 
A wide variety of complications may manifest during pregnancy. Some resolve during or 
at the conclusion of the gestational period, and others continue to impact women after pregnancy. 
In particular, preeclampsia is a condition that often unknowingly leaves women at a higher risk 
of developing cardiovascular disease (CVD) later in life versus women with normotensive 
pregnancies (Enkhmaa et al., 2016). Preeclampsia is understood to be a complex, rapidly-
progressive disorder, characterized by new onset hypertension during gestation in combination 
with signs of maternal organ failure (The American College of Obstetricians and Gynecologists, 
2013). Diagnostic criteria for preeclampsia can include proteinuria, thrombocytopenia, renal 
insufficiency, impaired liver function, pulmonary edema, headaches and vision changes (The 
American College of Obstetricians and Gynecologists, 2013). The correlation between 
preeclampsia and CVD is supported by evidence. However, susceptible women and healthcare 
providers are not adequately aware of the risk and associated strategies for risk reduction for the 
subsequent development of heart disease (Roth et al., 2019). It is critical that women with a 
history of preeclampsia are equipped with the proper education to advocate for their own health 
following a complicated pregnancy.  
In order to maintain the best possible cardiovascular profile after preeclampsia, 
interventions need to be implemented across a woman’s lifespan. These include lifestyle 
modifications and careful monitoring of CVD factors like blood pressure, blood sugar, and 
cholesterol. For the purpose of this project, the focus is on important factors contributing to 
cardiovascular health including blood pressure, cholesterol, blood sugar, physical activity, diet, 
weight, and smoking, recognized as “Life’s Simple 7” by the American Heart Association 
Running Head: CVD risk reduction following preeclampsia 
(AHA) (American Heart Association, n.d.). The goal of this project was to develop an 
educational resource to increase awareness of risk, promote self-advocacy and provide risk 
reduction strategies for cardiovascular disease among women after a preeclampsia complicated 
pregnancy.  
Background of the Problem 
Preeclampsia, among other hypertensive disorders of pregnancy, affects approximately 
three to eight percent of pregnancies across the world (Enkhmaa et al., 2016). These conditions 
are also associated with increased maternal and neonatal morbidity and mortality (Antza et al., 
2018). Clinical understanding of preeclampsia has evolved over time, now recognized as a 
highly complex, multisystem disorder with many implications for women during and after 
pregnancy (Anderson & Schmella, 2017). Preeclampsia was recognized as a risk factor for CVD 
in 1999 in a consensus panel statement by the AHA (Mosca et al., 1999). Since then, numerous 
studies have provided evidence to substantiate the connection between preeclampsia and the 
subsequent development of CVD. Yet, affected women remain unaware of their risk.  
This issue is compounded by the statistics associated with CVD and female mortality 
rates. Over the past thirty years, rates of preeclampsia have increased, affecting approximately 
3.4% of the 120 million deliveries in the United States (Turbeville & Sasser, 2020). CVD is the 
leading cause of mortality in women and is responsible for approximately 1 in 3 female deaths 
(Garcia et al., 2016). Evidence shows lifestyle modifications can improve patient’s 
cardiovascular profile and decrease premature death from CVD (Brown et al., 2018; Mosca et 
al., 2007). Currently, there is an absence in adequate translation of this evidence into practice. 
This means women with a history of preeclampsia are left with a duality of problems: they are 
unaware of their elevated risk of developing CVD and there is no defined structure in place to 
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guide the management of other modifiable CVD risk factors. An evidence-based practice (EBP) 
change is both appropriate and necessary to improve these patient’s outcomes (Brown et al., 
2018; Melnyk et al., 2017). Until evidence-based changes can be made to institutional policies 
and healthcare provider practices, patients need evidence-based customized education to provide 
them with the necessary awareness and appropriate actions to reduce their risk of developing 
CVD.  
Purpose of the Project 
The purpose of this project was to develop an educational resource to increase awareness 
of risk, promote self-advocacy and provide risk reduction strategies for cardiovascular disease 
among women after a preeclampsia complicated pregnancy. Awareness, advocacy, and risk 
reduction were identified as the defining pillars of this project. The combination of these three 
components are currently lacking in the translation from evidence to practice. Currently, 
evidence shows that women with a history of preeclampsia are not aware of their elevated risk of 
developing CVD and do not consider themselves at-risk cardiovascular patients (Seely et al., 
2013). The relationship between preeclampsia and CVD has been substantiated by evidence for 
the past twenty years (Wu et al., 2017), yet standardized preventative or screening measures are 
not universally implemented in practice. While this gap between evidence and practice still 
exists, it is important to implement strategies to assure affected women have the tools and 
knowledge to bridge that gap for their own health. Thus, providing women with customized 
education for how to address relevant cardiovascular risk factors with their healthcare provider 
after a pregnancy complicated by preeclampsia enables them to be advocates for their future 
health. Finally, equipped with the knowledge and confidence to facilitate a conversation with 
their healthcare provider, women will have the opportunity to be counseled on what actions to 
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take now and in the future to achieve and maintain an optimal cardiovascular profile.  
Significance of the Project 
The significance of this project is that cardiovascular risk can be reduced by increasing 
awareness, promoting self-advocacy and providing risk reduction strategies for women with a 
history of preeclampsia. Focus group studies have shown that women with a diagnosis of 
preeclampsia are often unaware of their elevated risk for developing CVD (Seely et al., 2013; 
Seely, Tsigas, & Rich-Edwards, 2015). The findings of these studies demonstrate a need for 
affected patients to be appropriately educated on how to reduce their risk of developing a disease 
that will affect them for the rest of their lives. Multiple participants in these studies identified 
customized education as a suggested solution to the existing knowledge deficit (Seely et al., 
2013; Seely, Tsigas, & Rich-Edwards, 2015).  
Significance of this project was further validated by support from stakeholders relevant to 
the affected population. Prior to this project, the Ohio State University Wexner Medical Center 
(OSUWMC) did not have any patient education available to inform patients of their increased 
risk of developing heart disease following a pregnancy complicated by preeclampsia. Without 
appropriate education, women are not aware that preeclampsia is a non-modifiable risk factor for 
CVD. Empowered by evidence-based education, women can act towards reducing their CVD 
risk. Delivery of evidence-based patient education functions to increase awareness among 
affected women and promote self-advocacy and risk reduction behaviors.  
Conceptual Frame of Reference  
A model for change to evidence-based practice (Rosswurm & Larrabee, 1999) was 
utilized as the theoretical framework to navigate through this project. The six steps of the model 
guided the process of developing evidence-based educational content that had not previously 
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been translated into practice at OSUWMC for CVD risk after preeclampsia. Rosswurm and 
Larrabee’s (1999) model, “supports evidence-based practice changes derived from a combination 
of quantitative and qualitative data, clinical expertise, and contextual evidence,” (p. 317) all of 
which were utilized in the completion of this project. Additionally, the Orem Self Care 
theoretical model was used to organize and construct the content of the patient education 
material (Hartweg, 1991). 
Definition of Terms 
Awareness: Knowledge and understanding that something is happening or exists. 
Advocacy: The act or process of supporting a cause or proposal. 
 
Risk reduction: A decrease in the probability of an adverse outcome. 
 
Chapter II: Review of Literature 
Cardiovascular Disease and Women  
 CVD is the leading cause of mortality in the United States. The terms cardiovascular 
disease and heart disease are used interchangeably to describe medical conditions involving the 
heart and blood vessels. CVD encompasses multiple pathologies including coronary artery 
disease, peripheral vascular disease, heart failure, hypertension, and stroke. Based on data 
collected from 2013-2016 by the National Health and Nutrition Examination Survey (NHANES), 
48% of adults 20 years and older have CVD, with prevalence increasing with age in both males 
and females (Virani et al., 2020). In the years 2013 to 2016, the prevalence of CVD among 
women ages twenty and older was approximately sixty million women, or 44.7% of the female 
population (Virani et al., 2020). A 2012 AHA survey reported 56% of women were aware of 
heart disease as the leading cause of death among females, an increase from 30% in 1997, with 
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awareness rates among black and Hispanic females lower that of white females (Virani et al., 
2020). 
 There are many risk factors that contribute to the development of CVD, many of which 
are modifiable and lifestyle-dependent. The most critical modifiable risk factors include blood 
pressure, cholesterol, blood sugar, activity level, diet, weight, and smoking, according to the 
AHA (American Heart Association, n.d.). Awareness of the importance of these health behaviors 
and measurements is widespread among providers and patients. Screening guidelines for these 
risk factors are dependent on a patient’s individual medical history and may take into 
consideration non-modifiable risk factors like family history. Screening tools designed to help 
providers predict an adult’s risk of experiencing a cardiovascular event include the Framingham 
Risk Score (FRS), Pooled Cohort Atherosclerotic Cardiovascular Disease (ASCVD) Risk 
Equations, Assessing Cardiovascular Risk using Scottish Intercollegiate Guidelines Network 
(ASSIGN), QRISK®2 (version two of the QRISK® CVD risk algorithm), Prospective 
Cardiovascular Münster (PROCAM), Systematic Coronary Risk Evaluation (SCORE), and 
UKPDS (Wallace, Ricco & Barrett, 2014). Each screening tool is derived from a different adult 
population, and therefore most suitable in practice for various populations.   
 There are many underrecognized, non-modifiable, female-specific risk factors for CVD, a 
group of which are hypertensive complications of pregnancy. In particular, preeclampsia is a 
hypertensive complication of pregnancy that doubles women’s risk for heart disease and 
quadruples the risk for high blood pressure (Preeclampsia Foundation, 2014). A Norwegian 
study showed 28.6% of women who were normotensive prior to pregnancy required 
pharmacologic intervention for high blood pressure within ten years of pregnancy complicated 
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by a hypertensive disorder (Virani et al., 2020). A history of preeclampsia offers an opportunity 
to identify women with an elevated risk for developing CVD (Kulinski, 2020).   
Awareness & Advocacy  
 The AHA first included hypertensive disorders of pregnancy in guidelines for women’s 
heart health over two decades ago (Mosca et al., 1999). However, affected women may be 
unaware of their elevated risk. Focus group studies have revealed affected women are unaware 
of their increased risk for heart disease, but are interested in learning what steps to take to reduce 
their risk (Seely et al., 2013). The women in the focus group identified the cost of healthy foods, 
familial commitments, and lack of time as barriers to adopting an ideal healthy lifestyle (Seely et 
al., 2013). They also identified a ‘web-based’ or ‘online’ format as the preferable delivery of 
risk-lowering resources and guidelines (Seely et al., 2013).  
 It is essential for the patient and the health care provider (HCP) to play an active role in 
chronic disease prevention. Often, as a woman’s primary care provider, OB/GYN’s have a 
unique opportunity to influence a woman’s health even after reproductive years by identifying 
risk factors for chronic conditions early-on (Roth et al., 2019). Six different studies addressing 
HCPs’ knowledge of the connection between preeclampsia and heart disease showed great 
variety in providers’ level of awareness (Roth et al., 2019). Current evidence suggests that there 
is ineffective and inconsistent communication between in-patient maternity HCPs and outpatient 
HCPs regarding a women’s history of a hypertensive disorder of pregnancy, the associated 
elevated risk for CVD, and need for follow-up (Roth et al., 2019). Experts recommend affected 
women seek referral from their obstetric provider to a primary care and/or cardiology HCP 
(Leslie & Briggs, 2019). The transition from acute inpatient care after a pregnancy complicated 
by preeclampsia to a long-term outpatient provider is essential for monitoring markers of 
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cardiovascular health and having access to appropriate referrals and counseling. Providers are 
not always adequately aware of their role and responsibility in this transition in care, however 
women’s cardiovascular health outcomes can improve with enhanced communication strategies 
and collaboration between OB/GYN’s and cardiologists (Brown et al., 2018). A scoping review 
found providers are unaware of the elevated risk for CVD following a preeclamptic pregnancy 
and preeclampsia is underrecognized in a patient’s history as a clue for CVD development, 
globally (Roth, LeMarquand, Henry, & Homer, 2019).  
Risk Reduction  
 As preeclampsia is not widely recognized in practice as a cardiovascular risk, screening 
guidelines for CVD are not routinely implemented. The PF’s 2019 position paper on 
preeclampsia and heart disease in women endorses the inclusion of prenatal and delivery records 
in a woman’s medical record, a thorough consideration of medical and family health history in 
the calculation of risk for developing CVD, and the assessment for metabolic syndrome because 
of the commonalities in presentation between metabolic syndrome and CVD (Leslie & Briggs, 
2019.) Suggested lifestyle modifications include not smoking, having a healthy BMI (less than 
25 kg/m2), moderate activity at least 150 minutes per week, and a healthy diet like the AHA’s 
Dietary Approaches to Stop Hypertension diet (Leslie & Briggs, 2019).  There is limited and 
inconsistent evidence in the literature about the efficacy of lifestyle changes as a risk reduction 
strategy for specifically the affected population. One statistical analysis of the effects of lifestyle 
modifications as a CVD risk reduction strategy for preeclampsia survivors was shown to reduce 
risk by 4 to 13% (Stampfer, Hu, Manson, Rimm, & Willett, 2000). Another study found that 
incidence of a coronary event is more than 80% lowered by healthful lifestyle choices like not 
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smoking, eating healthy, half an hour of vigorous exercise a day, not being overweight, and 
moderate alcohol consumption (Stampfer, Hu, Manson, Rimm, & Willett, 2000). 
 Healthful lifestyle choices are important for all individuals to reduce risk of developing 
CVD, especially for those with a history of a pregnancy complicated by a hypertensive disorder. 
Appropriate screenings and referrals for modifiable risk factors should be conducted at outpatient 
visits. The indication for interventions including pharmacologic strategies should also be 
reviewed at outpatient visits. Specific screening technology and guidelines for the affected 
population should be enhanced to identify varying levels of risk and appropriate interventions 
throughout a woman’s lifetime after a preeclamptic pregnancy. Women should be made aware of 
their elevated risk and feel empowered to begin a dialogue with a long-term care provider about 
risk-reduction strategies. Involved providers should leverage modern medical technology to 
improve the continuity of care provided for the affected population.  
 
Chapter III: Methodology  
This effort to deliver adequate and appropriate education to women for how to reduce 
their risk of developing CVD following a preeclamptic pregnancy is motivated by necessity. The 
absence of sufficient patient education leaves these women in a self-care deficit. This deficiency 
is the result of an imbalance between self-care demand and self-care ability. As of now, the 
demand for self-care is greater than women’s ability to self-care. Unsuitable to meet the 
requisites for promoting their most favorable cardiovascular profile following preeclampsia, 
these women are susceptible to a variety of potential health complications.  
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Rosswurm and Larrabee’s (1999) “Model for Change to Evidence-Based Practice” 
guided the design of this project. The following describes each step of the model as it pertains to 
this project. 
Model for Change to Evidence-Based Practice 
Step 1: Assess need for change in practice 
Stakeholders were included in problem identification. Stakeholders from College of 
Nursing (CON) and OSUWMC identified the absence of awareness, advocacy and risk reduction 
for CVD following a preeclamptic pregnancy as the problem. Internal data from OSUWMC 
revealed there was no evidence-based patient education specific to the problem. External data 
from studies and publications around the world indicated the problem was not unique to 
OSUWMC. Stakeholders verified the need for an intervention to reduce women’s risk of 
developing CVD after a preeclampsia complicated pregnancy by increasing awareness of risk, 
promoting self-advocacy and providing risk reduction strategies. 
 Step 2: Link problem with interventions and outcomes 
 Stakeholders arrived at evidence-based patient education as the appropriate intervention 
to the problem identified in step one. Educational content would be derived from evidence 
provided by external experts in the fields of women’s health, obstetrics, gynecology and 
cardiology. Internal experts in patient education would ensure appropriateness of educational 
content (clarity, reading level, etc.) prior to implementation. Implementation into OSUWMC 
would act as measurable indication of satisfactory outcome.   
 Step 3: Synthesize best evidence 
The review of literature yielded ample evidence to support the necessity for patient 
education for the affected population to reduce risk of developing CVD. Evidence was weighed 
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based on journal’s impact factor and the source’s relevance to purpose of the project. PubMed 
and CINAHL were used to conduct literature review. Search terms included “cardiovascular 
disease” or “heart disease”, “preeclampsia”, “risk reduction”, “women” and “prevention”. 
Evidence from databases supported the necessity of intervention for the problem identified in 
step one. Health information from PF and AHA substantiated the evidence to be included in 
patient education content. Testimonials from stakeholders increased strength of evidence to 
support a change in practice. The project was deemed feasible by stakeholders and no risks were 
identified. CVD risk reduction after a preeclampsia complicated pregnancy was recognized as a 
benefit of the project.  
 Step 4: Design a change in practice 
 Introducing an evidence-based patient education piece for CVD risk reduction after a 
preeclampsia complicated pregnancy was the proposed change to practice. The production of the 
patient education piece required the collaboration of many different professionals from a variety 
of disciplines and departments at the OSUWMC and CON. Individuals from the CON, 
postpartum nursing education, and the patient education resource team worked together to 
produce the most efficient and effective delivery of the educational content for the patients. All 
collaborators were made aware of the purpose of this project and contributions were within 
respective defined scope of practices. 
 The Orem Self Care Deficit Theory was utilized as a framework for curating the content 
included in the patient education designed to reduce women’s risk of developing CVD after a 
preeclampsia complicated pregnancy by increasing awareness of risk, promoting self-advocacy 
and providing risk reduction strategies. The theory operates on a number of assumptions, 
multiple of which align with the purpose of the project. These pertinent assumptions include: 
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individuals should be self-sufficient and responsible for their care, and a knowledge of potential 
health complications is required to promote self-care behaviors (Hartweg, 1991).  
 The three components of the theory and their respective subcomponents informed the 
curation of health information and risk reduction strategies to be included in the educational 
content. They are the theory of self-care, theory of self-care deficit, and theory of nursing system 
(Hartweg, 1991). The theory of self-care recognizes the therapeutic self-care demand, requisites, 
and agency of women with a history of preeclampsia in the contemporary health care system. 
The theory of self-care deficit describes a person’s inability to promote their own well-being. For 
the purposes of this project, the self-care deficit is women’s lack of awareness of their increased 
risk for CVD and their subsequent inability to advocate for their own health. The final 
component, the theory of nursing systems, describes how the nurse can act to meet the self-care 
requisites of the patient. In this project, patient education is the intervention designed to meet the 
self-care requisites of affected women.  
 Health information from the PF website supplemented by recommendations and 
guidelines published by the AHA were the principle sources from which content for the patient 
education was collected (Brown et al., 2018; Preeclampsia Foundation, n.d.). The PF is the 
authority patient advocacy organization in the United States for women who are affected by any 
of the hypertensive disorders of pregnancy. An online PF publication titled “Take Heart and 
Take Care: Preeclampsia May Be Associated with Heart Disease and Stroke Later in Life” 
highlights statistics regarding increased risk for CVD, modifiable risk factors to discuss with 
health care providers, and what affected woman can do to lower their risk (Appendix 1). The 
AHA is an authoritative entity in the field of cardiovascular health. The PF recommendations are 
echoed and expanded upon by an AHA publication titled “Promoting Risk Identification and 
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Reduction of Cardiovascular Disease in Women Through Collaboration With Obstetricians and 
Gynecologists” (Brown et al., 2018). This publication offers more precise primary and secondary 
prevention strategies for women and CVD.  Upon completion of educational content curation, 
implementation was dependent upon the patient education resource team at OSUWMC 
implementing the evidence-based education into practice.  
Population and Setting 
 The population exposed to the patient education was all inpatient postpartum women with 
a diagnosis of preeclampsia at OSUWMC Department of Maternal and Infant Health. There were 
no exclusion criteria. The evidence-based education is suitable for all women to receive for the 
purpose of awareness of future cardiovascular risk.  
 
Chapter IV: Results 
 Step 5: Implement and evaluate the practice change 
 Patient education was implemented at OSUWMC in December 2018. It was linked to 
patient’s MyChart and is accessible on OSUWMC’s patient education platform 
(patienteducation.osumc.edu). It can be found in the form of a PDF document under the topic of 
‘Heart Diseases’ with the title ‘Risk Factors for Heart Disease: After a Preeclamptic Pregnancy’.  
The product of the project was evidence-based educational content designed to bring awareness, 
promote advocacy and encourage risk reduction strategies. The content of the patient education 
includes information about risk for CVD after a preeclampsia-complicated pregnancy and 
primary and secondary preventative strategies. (See Appendix 2.) 
The educational content was included in the discharge paperwork patients received when 
discharged home from the postpartum nursing unit. Focus groups of women in the postpartum 
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period of a preeclamptic pregnancy have recognized an online-accessible format as the preferred 
method of receiving information on this topic (Seely et al., 2013; Skurnik et al., 2016). 
OSUWMC patients have access to the online platform, “MyChart” (mychart.osu.edu), where 
they can find and access at any time their tailored discharge instructions, including the CVD risk 
reduction education. 
 Step 6: Integrate and maintain the practice change 
 Since implementation, OSUWMC has adopted a different discharge bundle for affected 
patients, limiting ability to evaluate sustained practice change.  
 
Chapter V: Conclusions & Discussion 
Conclusions 
 Identifying and critically assessing the need for this project lead to the design of this 
patient-centric educational content and established a foundation for evidence-based practice 
change on the institutional and practitioner level.  The purpose of this project was to develop an 
educational resource to increase awareness of risk, promote self-advocacy and provide risk 
reduction strategies for cardiovascular disease among women after a preeclampsia complicated 
pregnancy.  
Awareness of one’s cardiovascular health and how to improve it is important for all 
women, especially those with unmodifiable risk factors like preeclampsia. Given the reality of 
morbidity and mortality associated with CVD, HCPs have an obligation to inform women of risk 
factors and how to reduce their risk. Both acute and outpatient providers caring for women have 
opportunities to reduce risk through education, screening and counseling. 
Limitations 
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  Limitations of the content’s design included the necessary brevity and generalization of 
guidelines and recommendations to make the education applicable to a variety of patients. The 
institutional change of education delivery limited the evaluation of the sustained practice change. 
Implications of this Project 
 Given the morbidity and mortality associated with CVD, practitioners have an obligation 
to inform women of risk factors and risk reduction strategies. Further evidence-based changes to 
practice are indicated to reduce risk of developing CVD after a preeclamptic pregnancy. 
Evaluation of the influence of education on the advocacy, awareness and risk reduction regarding 
CVD in women after preeclampsia would inform the impact of this project. 
Recommendations  
 Chronic disease prevention is a responsibility of all clinicians caring for women across 
the lifetime. An active approach to prevention and risk reduction strategies informed by 
providers are necessary for women to achieve their most favorable cardiovascular profile.  
Healthful lifestyle choices are an appropriate teaching point during every patient-provider 
interaction.  
 Improved coordination and communication between OBGYNs and outpatient providers, 
cardiologists, primary care, etc., would benefit patients across the care continuum. HCPs could 
better assess the individual’s needs and determine appropriate plans for chronic disease risk 
reduction and/or management strategies. In order to achieve this, providers must be equipped 
with evidence-based knowledge of non-modifiable and modifiable risk factors for chronic 
pathologies.  
 Standardized screening guidelines for CVD can be improved by considering pregnancy-
related non-modifiable risk factors as well as modifiable risk factors. Obtaining a complete 
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health history, including obstetric history, is the first step in creating a comprehensive risk 
reduction plan for patients’ lifelong health. Measurable indicators of cardiovascular health 
including, blood pressure, blood glucose, weight, cholesterol, etc., should be recorded based on 
evidence-based guidelines. Regular screening can enhance patients’ understanding of the 
influence of lifestyle choices on their health. Reassessment of risk factors should be a routine 
part of outpatient care.  
 Due to the significance of modifiable risk factors in determining one’s cardiovascular 
health, education on healthy lifestyles and behaviors should be a cornerstone of care for all 
women.  Poor dietary choices and inadequate activity levels are major contributors to chronic 
diseases, meaning decreased quality of life and increased healthcare costs. Providers leveraging 
modern technology can improve the care continuum and decrease the burden of chronic diseases 
for patients.  Electronic medical records and digital patient profiles are a powerful platform for 
communication between providers and patients. Optimization of technology promotes patient-
centric care and can be used by providers to institute preventative measures and also to educate 
and empower women. 
 All women deserve to be aware of risk factors for chronic conditions, specifically CVD, 
because of the associated morbidity and mortality. Affected women need to feel empowered to 
advocate for their own health and engage in a dialogue with their providers in order to take 
active steps towards a healthier future.  
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Appendix 
 
 
 
Appendix 1. Preeclampsia Foundation. (n.d.). Take heart and take care: Preeclampsia may be 
associated with heart disease and stroke later in life [Illustration]. Retrieved from 
https://www.preeclampsia.org/health-information/heart-disease-stroke 
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Appendix 2. Screenshot of evidence-based patient education content that is now available to 
patients at https://patienteducation.osumc.edu/Documents/pre-clam.pdf. “Risk for heart disease” 
section of education was added as a result of this project and published on December 17, 2018. 
Other health information in the education was updated to reflect most recent evidence. 
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